Your browser doesn't support javascript.
loading
Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer.
Shakya, R; Tarulli, G A; Sheng, L; Lokman, N A; Ricciardelli, C; Pishas, K I; Selinger, C I; Kohonen-Corish, M R J; Cooper, W A; Turner, A G; Neilsen, P M; Callen, D F.
Affiliation
  • Shakya R; Centre for Personalised Cancer Medicine, Cancer Therapeutics Laboratory, School of Medicine, Faculty of Health Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
  • Tarulli GA; Dame Roma Mitchell Cancer Research Laboratories (DRMCRL), School of Medicine, Faculty of Health Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
  • Sheng L; Centre for Personalised Cancer Medicine, Cancer Therapeutics Laboratory, School of Medicine, Faculty of Health Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
  • Lokman NA; Discipline of Obstetrics and Gynaecology, School of Medicine, Faculty of Health Sciences, Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
  • Ricciardelli C; Adelaide Proteomics Centre, School of Molecular and Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
  • Pishas KI; Discipline of Obstetrics and Gynaecology, School of Medicine, Faculty of Health Sciences, Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
  • Selinger CI; Centre for Personalised Cancer Medicine, Cancer Therapeutics Laboratory, School of Medicine, Faculty of Health Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
  • Kohonen-Corish MRJ; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Cooper WA; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Turner AG; St Vincent's Clinical School, UNSW Australia, Sydney, New South Wales, Australia.
  • Neilsen PM; School of Medicine, University of Western Sydney, Parramatta, New South Wales, Australia.
  • Callen DF; School of Medicine, University of Western Sydney, Parramatta, New South Wales, Australia.
Oncogene ; 36(31): 4469-4480, 2017 08.
Article in En | MEDLINE | ID: mdl-28368395
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alpha 1-Antitrypsin / Tumor Suppressor Protein p53 / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alpha 1-Antitrypsin / Tumor Suppressor Protein p53 / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Country of publication: